米国の耳鼻咽喉科用機器市場規模、シェア、動向分析レポート：製品別、地域別、セグメント別予測、2024～2030年

米国の耳鼻咽喉科用機器市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、米国の耳鼻咽喉科用機器市場規模は2030年までに115億米ドルに達すると予測され、2024年から2030年までのCAGRは4.9％で成長すると予測されています。

耳鼻咽喉科疾患の有病率の増加、医療機器の技術進歩、ヘルスケア支出の増加、利用可能な治療オプションに関する患者の意識の高まりが市場成長を促進しています。市場には、診断機器（内視鏡、聴力計）、手術機器（動力手術機器、ハンドヘルド機器）、補聴器、埋め込み型補聴器、人工音声機器、その他などのセグメントに分類された幅広い製品が含まれます。

米国の高齢化も市場成長の大きな要因です。加齢に伴い、加齢性難聴、平衡障害、その他の耳鼻咽喉科疾患を発症しやすくなり、医療介入が必要となります。老年人口の増加により、補聴器や増幅装置など、高齢患者特有のニーズに合わせた耳鼻咽喉科ソリューションの需要が高まっています。

技術の進歩、特に人工知能（AI）と機械学習（ML）の広範な採用は、聴覚製品の継続的な技術革新とともに、さまざまな業界にわたって市場の成長を推進する上で重要な役割を果たしています。こうした技術の進歩は、ビジネスの運営方法を再構築し、効率性、生産性、全体的なパフォーマンスを向上させています。例えば、2023年2月、Oticon Medical A/Sは新しいPolaris R処理チップの機能強化を発表しました。この更新されたチップは、音響処理風力安定装置への新しいアプローチのためのオンボードDeep Neural Networkを組み込んでいます。

米国の耳鼻咽喉科用機器市場レポートハイライト：

• 外科用耳鼻咽喉科用機器分野が2023年に30.3%の最大売上シェアで市場を牽引。耳鼻咽喉科手術における低侵襲手技へのシフトが、患者の予後改善と回復時間の短縮を提供する革新的な手術機器への需要を促進しています。
• 聴覚インプラント分野は、人工内耳に関する意識の高まりと難聴の有病率の増加により、予測期間中に最も速いCAGRで成長すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の耳鼻咽喉科用機器市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場 促進要因分析
  • 市場抑制要因分析
• 米国の耳鼻咽喉科用機器市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国の耳鼻咽喉科用機器市場：製品別推定・動向分析

• フォーム市場シェア、2023年と2030年
• セグメントダッシュボード
• 米国の耳鼻咽喉科用機器市場製品別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 診断耳鼻咽喉科用機器
• 手術耳鼻咽喉科用機器
• 補聴器
• 人工内耳
• 鼻用スプリント

第5章 米国の耳鼻咽喉科用機器市場：地域別推定・動向分析

• 地域別市場シェア、2023年および2030年
• 米国の耳鼻咽喉科用機器市場地域別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 西部
• 中西部
• 北東部
• 南西部
• 南東部

第6章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
• 企業プロファイル
  • Ambu A/S.
  • Cochlear Ltd.
  • Demant A/S
  • GN Store Nord A/S
  • KARL STORZ SE &Co. KG
  • Olympus Corporation
  • PENTAX Medical
  • RION Co., Ltd.
  • Sonova
  • Starkey Laboratories, Inc.
  • Stryker
  • Nico Corporation
  • Nemera

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. ENT devices market, by product, 2018 - 2030 (USD Million)
• Table 3 U.S. ENT devices market, by region, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 US ENT devices market: market outlook
• Fig. 10 US ENT devices competitive insights
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 U.S. ENT devices market driver impact
• Fig. 15 U.S. ENT devices market restraint impact
• Fig. 16 U.S. ENT devices market: Product movement analysis
• Fig. 17 U.S. ENT devices market: Product outlook and key takeaways
• Fig. 18 Diagnostic ENT devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Rigid endoscopes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Sinuscopes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Otoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Laryngoscopes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Flexible endoscopes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Bronchoscopes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Laryngoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Nasopharyngoscopes market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Robot assisted endoscope market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Hearing screening device market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Surgical ENT devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Radiofrequency handpieces market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Otological drill burrs market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 ENT hand instruments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Sinus dilation devices market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Nasal packing devices market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Hearing aids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Hearing implants market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Nasal splints market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 US ENT devices market: Regional movement analysis
• Fig. 40 US ENT devices market: Regional outlook and key takeaways
• Fig. 41 West market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)

U.S. ENT Devices Market Growth & Trends:

The U.S. ENT devices market size is anticipated to reach USD 11.5 billion by 2030 and is projected to grow at a CAGR of 4.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of ENT disorders, technological advancements in medical devices, rising healthcare expenditure, and growing awareness among patients about available treatment options are driving market growth. The market includes a wide array of products categorized into segments such as diagnostic devices (endoscopes, audiometers), surgical devices (powered surgical instruments, handheld instruments), hearing aids, implantable hearing devices, voice prosthesis devices, and others.

The aging population in the U.S. is another significant factor contributing to the market growth. As individuals age, they are more prone to developing age-related hearing loss, balance disorders, and other ENT conditions that require medical intervention. The increasing geriatric population has led to a higher demand for hearing aids, amplification devices, and other ENT solutions tailored to meet the specific needs of older patients.

The advancement of technology, particularly the widespread adoption of artificial intelligence (AI) and machine learning (ML), along with continuous innovations in auditory products, is playing a significant role in propelling market growth across various industries. These technological advancements are reshaping how businesses operate, enhancing efficiency, productivity, and overall performance. For instance, in February 2023, Oticon Medical A/S announced new Polaris R processing chip enhancements. This updated chip incorporates an onboard Deep Neural Network for a novel approach to sound processing wind stabilizer.

U.S. ENT Devices Market Report Highlights:

• The surgical ENT devices segment led the market with the largest revenue share of 30.3% in 2023. The shift towards minimally invasive procedures in ENT surgeries has propelled the demand for innovative surgical devices that offer improved patient outcomes and reduced recovery times
• The hearing implants segment is anticipated to grow at the fastest CAGR during the forecast period, owing to therising awareness about cochlear implants and the increasing prevalence of hearing loss

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
• 2.3. Competitive Insights

Chapter 3. U.S. ENT Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. ENT Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. ENT Devices Market: Product Estimates & Trend Analysis

• 4.1. Form Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. ENT Devices Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Diagnostic ENT Devices
    • 4.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.1.2. Rigid Endoscopes
    • 4.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.1.2.2. Sinusscopes
    • 4.4.1.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.1.2.3. Otoscopes
    • 4.4.1.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.1.2.4. Laryngoscopes
    • 4.4.1.2.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.1.3. Flexible Endoscopes
    • 4.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.1.3.2. Bronchoscopes
    • 4.4.1.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.1.3.3. Laryngoscopes
    • 4.4.1.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.1.3.4. Nasopharyngoscopes
    • 4.4.1.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.1.4. Robot Assisted Endoscopes
    • 4.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.1.5. Hearing Screening Device Endoscopes
    • 4.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.2. Surgical ENT Devices
    • 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.2. Radiofrequency Handpieces
    • 4.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.3. Otological Drill Burrs
    • 4.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.4. ENT Hand Instruments
    • 4.4.2.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.5. Sinus Dilation Devices
    • 4.4.2.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.6. Nasal Packing Devices
    • 4.4.2.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2.7. Others
    • 4.4.2.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.3. Hearing Aids
    • 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.4. Hearing Implants
    • 4.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.5. Nasal Splints
    • 4.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. ENT Devices Market: Region Estimates & Trend Analysis

• 5.1. Regional Market Share, 2023 & 2030
• 5.2. U.S. ENT Devices Market by Region Outlook
• 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
  • 5.3.1. West
    • 5.3.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.2. Midwest
    • 5.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.3. Northeast
    • 5.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.4. Southwest
    • 5.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.3.5. Southeast
    • 5.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
• 6.3. Vendor Landscape
  • 6.3.1. List of key distributors and channel partners
  • 6.3.2. Key customers
  • 6.3.3. Key company heat map analysis, 2023
• 6.4. Company Profiles
  • 6.4.1. Ambu A/S.
    • 6.4.1.1. Company overview
    • 6.4.1.2. Financial performance
    • 6.4.1.3. Product benchmarking
    • 6.4.1.4. Strategic initiatives
  • 6.4.2. Cochlear Ltd.
    • 6.4.2.1. Company overview
    • 6.4.2.2. Financial performance
    • 6.4.2.3. Product benchmarking
    • 6.4.2.4. Strategic initiatives
  • 6.4.3. Demant A/S
    • 6.4.3.1. Company overview
    • 6.4.3.2. Financial performance
    • 6.4.3.3. Product benchmarking
    • 6.4.3.4. Strategic initiatives
  • 6.4.4. GN Store Nord A/S
    • 6.4.4.1. Company overview
    • 6.4.4.2. Financial performance
    • 6.4.4.3. Product benchmarking
    • 6.4.4.4. Strategic initiatives
  • 6.4.5. KARL STORZ SE & Co. KG
    • 6.4.5.1. Company overview
    • 6.4.5.2. Financial performance
    • 6.4.5.3. Product benchmarking
    • 6.4.5.4. Strategic initiatives
  • 6.4.6. Olympus Corporation
    • 6.4.6.1. Company overview
    • 6.4.6.2. Financial performance
    • 6.4.6.3. Product benchmarking
    • 6.4.6.4. Strategic initiatives
  • 6.4.7. PENTAX Medical
    • 6.4.7.1. Company overview
    • 6.4.7.2. Financial performance
    • 6.4.7.3. Product benchmarking
    • 6.4.7.4. Strategic initiatives
  • 6.4.8. RION Co., Ltd.
    • 6.4.8.1. Company overview
    • 6.4.8.2. Financial performance
    • 6.4.8.3. Product benchmarking
    • 6.4.8.4. Strategic initiatives
  • 6.4.9. Sonova
    • 6.4.9.1. Company overview
    • 6.4.9.2. Financial performance
    • 6.4.9.3. Product benchmarking
    • 6.4.9.4. Strategic initiatives
  • 6.4.10. Starkey Laboratories, Inc.
    • 6.4.10.1. Company overview
    • 6.4.10.2. Financial performance
    • 6.4.10.3. Product benchmarking
    • 6.4.10.4. Strategic initiatives
  • 6.4.11. Stryker
    • 6.4.11.1. Company overview
    • 6.4.11.2. Financial performance
    • 6.4.11.3. Product benchmarking
    • 6.4.11.4. Strategic initiatives
  • 6.4.12. Nico Corporation
    • 6.4.12.1. Company overview
    • 6.4.12.2. Financial performance
    • 6.4.12.3. Product benchmarking
    • 6.4.12.4. Strategic initiatives
  • 6.4.13. Nemera
    • 6.4.13.1. Company overview
    • 6.4.13.2. Financial performance
    • 6.4.13.3. Product benchmarking
    • 6.4.13.4. Strategic initiatives